C linical trials of therapeutic agents for heart failure with preserved ejection fraction (HFpEF) have yielded little beyond disappointment for physicians caring for these ubiquitous patients who comprise over one-half of the annual 1,000,000 heart failure (HF) discharges in the United States (1) . The most recent and largest HFpEF trial,
TOPCAT (Treatment Of Preserved Cardiac Function
Heart Failure with an Aldosterone Antagonist), although nominally negative, may reveal insights into the risk of different patient subgroups. HFpEF has changed names, has struggled with identity crises, and likely reflects several different processes (2) . Recently, the application of computerized analysis and grouping of phenotypic variables has suggested 3 subsets of patients with HFpEF (3).
Phenotypically characterizing the heterogeneous constituents of the HFpEF syndrome into clinically meaningful groups may allow researchers and clinicians to move toward a future of precision medicine.
QRS duration derives from a simple, inexpensive, century-old, universally available test. Furthermore, QRS duration predicts adverse cardiac outcomes in community-based populations and in patients with heart failure with reduced ejection fraction (HFrEF) (4, 5) . Whether QRS duration has prognostic importance in HFpEF is unclear. So, in this issue of JACC:
Heart Failure, Joseph et al. Figure 1A from their paper (6) reveals a few patients with QRS duration w50 ms, which is unexpectedly short because only 2% of normal individuals exhibit a QRS below 69 ms (7) . Nevertheless, QRS duration is generally accurate, and this is a minor point. However, QRS morphology, especially left bundle branch block (LBBB), is less "black and white"; indeed, LBBB is increasingly categorized as "strict" or not (8) . A prolonged QRS ($120 ms) was observed in 17.9% of TOPCAT patients. According to investigator-entered data, more than one-half of the prolonged QRS tracings reflected nonspecific intraventricular conduction delay; that is, right bundle branch block (5%) and LBBB (3.9%) were uncommon in TOPCAT. Previously, another broad HF study identified bundle branch block one-half as frequently in the HFpEF cohort as in the HFrEF cohort (w14% vs w30%) (9) . Interestingly, a wide QRS was more than twice as prevalent in the TOPCAT patients enrolled in the Americas (25.3%) as those from Russia/Georgia (10.2%). This marked geographic variation had surfaced earlier, as the primary endpoint occurred only one-third as often in the Russia/Georgia subset (2).
Several characteristics predicted QRS $120 ms, including older age; male sex; white race; and lower intriguingly exhibited significantly prolonged QRS (3) .
Having arrived at a focus on QRS duration by either the low or high (tech) road, we still have our work cut out for us to use this knowledge to advance therapy in HFpEF.
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